Nemaura Medical Inc. logo

NMRD

NASDAQ

Nemaura Medical Inc.

SectorHealth CareIndustryMedical/Dental Instruments
$0.12-0.01 (-5.38%)
Website
News25/Ratings2

Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes diagnostic medical devices. It provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company was founded in 2009 and is based in New York, New York.

Latest news

25 items